Abstract
The specific functions of plasminogen, stromal plasminogen activator, stromal plasminogen activator receptor, and stromal plasminogen activator inhibitor in the progression of the murine soft tissue sarcoma, T241 were investigated. Negation of plasminogen to the tumor blunted the orthotopic growth of the sarcoma in syngeneic mice. The reduced tumor growth was associated with a dramatic increase in tumor-infiltrating F4/80-positive macrophages and a diminution of vessel density, but not with obvious differences in fibrin and collagen deposition, or invasiveness of the tumor. Ablation of plasminogen activation by the tumor stroma only modestly impaired the prolonged growth of the sarcoma, suggesting that tumor cell-produced plasminogen activator is sufficient to mediate productive plasminogen activation. Plasminogen facilitated sarcoma progression, angiogenesis, and suppression of macrophage infiltration in the absence of either stromal urokinase plasminogen activator receptor or stromal plasminogen activator inhibitor. These data demonstrate that tumor cell-produced plasminogen activator and host plasminogen cooperate to facilitate soft tissue sarcoma growth and suppress the accumulation of tumor-infiltrating macrophages.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Alleva DG, Burger CJ, Elgert KD . 1994 J. Immunol. 153: 1674–1686
Andreasen PA, Egelund R, Petersen HH . 2000 Cell. Mol. Life Sci. 57: 25–40
Andreasen PA, Kjøller L, Christensen L, Duffy MJ . 1997a Int. J. Cancer 72: 1–22
Andreasen PA, Kjøller L, Christensen L, Duffy MJ . 1997b Int. J. Cancer 72: 1–22
Bajou K, Noel A, Gerard RD, Masson V, Brunner N, Holst-Hansen C, Skobe M, Fusenig NE, Carmeliet P, Collen D, Foidart JM . 1998 Nat. Med. 4: 923–928
Baker MS, Bleakley P, Woodrow GC, Doe WF . 1990 Cancer Res. 50: 4676–4684
Beck JM, Preston AM, Gyetko MR . 1999 Infect. Immun. 67: 879–884
Blasi F . 1999 Apmis 107: 96–101
Boer PH, Potten H, Adra CN, Jardine K, Mullhofer G, McBurney MW . 1990 Biochem. Genet. 28: 299–308
Bugge TH, Flick MJ, Danton MJ, Daugherty CC, Romer J, Danø K, Carmeliet P, Collen D, Degen JL . 1996a Proc. Natl. Acad. Sci. USA 93: 5899–5904
Bugge TH, Flick MJ, Daugherty CC, Degen JL . 1995a Genes Dev. 9: 794–807
Bugge TH, Kombrinck KW, Flick MJ, Daugherty CC, Danton MJ, Degen JL . 1996b Cell 87: 709–719
Bugge TH, Kombrinck KW, Xiao Q, Holmback K, Daugherty CC, Witte DP, Degen JL . 1997 Blood 90: 4522–4531
Bugge TH, Lund LR, Kombrinck KK, Nielsen BS, Holmback K, Drew AF, Flick MJ, Witte DP, Danø K, Degen JL . 1998 Oncogene 16: 3097–3104
Bugge TH, Suh TT, Flick MJ, Daugherty CC, Romer J, Solberg H, Ellis V, Danø K, Degen JL . 1995b J. Biol. Chem. 270: 16886–16894
Carmeliet P, Kieckens L, Schoonjans L, Ream B, van Nuffelen A, Prendergast G, Cole M, Bronson R, Collen D, Mulligan RC . 1993 J. Clin. Invest. 92: 2746–2755
Carmeliet P, Schoonjans L, Kieckens L, Ream B, Degen J, Bronson R, De Vos R, van den Oord JJ, Collen D, Mulligan RC . 1994 Nature 368: 419–424
Chapman HA, Wei Y . 2001 Thromb. Haemost. 86: 124–129
Crowley CW, Cohen RL, Lucas BK, Liu G, Shuman MA, Levinson AD . 1993 Proc. Natl. Acad. Sci. USA 90: 5021–5025
Cubellis MV, Andreasen P, Ragno P, Mayer M, Danø K, Blasi F . 1989 Proc. Natl. Acad. Sci. USA 86: 4828–4832
Danø K, Andreasen PA, Grondahl-Hansen J, Kristensen P, Nielsen LS, Skriver L . 1985 Adv. Cancer Res. 44: 139–266
Danø K, Romer J, Nielsen BS, Bjorn S, Pyke C, Rygaard J, Lund LR . 1999 Apmis 107: 120–127
De Petro G, Tavian D, Copeta A, Portolani N, Giulini SM, Barlati S . 1998 Cancer Res. 58: 2234–2239
Declerck PJ, Carmeliet P, Verstreken M, De Cock F, Collen D . 1995a J. Biol. Chem. 270: 8397–8400
Declerck PJ, Verstreken M, Collen D . 1995b Thromb. Haemost. 74: 1305–1309
Devy L, Blacher S, Grignet-Debrus C, Bajou K, Masson V, Gerard RD, Gils A, Carmeliet G, Carmeliet P, Declerck PJ, Noel A, Foidart JM . 2002 FASEB J. 16: 147–154
Dinapoli MR, Calderon CL, Lopez DM . 1996 J. Exp. Med. 183: 1323–1329
Dublin E, Hanby A, Patel NK, Liebman R, Barnes D . 2000 Am. J. Pathol. 157: 1219–1227
Duffy MJ, Reilly D, O'Sullivan C, O'Higgins N, Fennelly JJ, Andreasen P . 1990 Cancer Res. 50: 6827–6829
Elgert KD, Alleva DG, Mullins DW . 1998 J. Leukoc. Biol. 64: 275–290
Ellis V, Danø K . 1991 Semin. Thromb. Hemost. 17: 194–200
Ellis V, Behrendt N, Danø K . 1991 J. Biol. Chem. 266: 12752–12758
Ellis V, Wun TC, Behrendt N, Ronne E, Danø K . 1990 J. Biol. Chem. 265: 9904–9908
Foekens JA, Schmitt M, van Putten WL, Peters HA, Bontenbal M, Janicke F, Klijn JG . 1992 Cancer Res. 52: 6101–6105
Ganesh S, Sier CF, Griffioen G, Vloedgraven HJ, de Boer A, Welvaart K, van de Velde CJ, van Krieken JH, Verheijen JH, Lamers CB . 1994a Cancer Res. 54: 4065–4071
Ganesh S, Sier CF, Heerding MM, Griffioen G, Lamers CB, Verspaget HW . 1994b Lancet 344: 401–402
Geran RI, Greenberg NH, MacDonald MM, Schmacher AM, Abbot B . 1972 Cancer Chemotherapy Reports 3: 1
Goguen JD, Bugge T, Degen JL . 2000 Methods 21: 179–183
Grondahl-Hansen J, Christensen IJ, Rosenquist C, Brunner N, Mouridsen HT, Danø K, Blichert-Toft M . 1993 Cancer Res. 53: 2513–2521
Gutierrez LS, Schulman A, Brito-Robinson T, Noria F, Ploplis VA, Castellino FJ . 2000 Cancer Res. 60: 5839–5847
Hall SW, Humphries JE, Gonias SL . 1991 J. Biol. Chem. 266: 12329–12336
Hearing VJ, Law LW, Corti A, Appella E, Blasi F . 1988 Cancer Res. 48: 1270–1278
Heiss MM, Allgayer H, Gruetzner KU, Funke I, Babic R, Jauch KW, Schildberg FW . 1995 Nat. Med. 1: 1035–1039
Hienert G, Kirchheimer JC, Pfluger H, Binder BR . 1988 J. Urol. 140: 1466–1469
Hiraoka N, Allen E, Apel IJ, Gyetko MR, Weiss SJ . 1998 Cell 95: 365–377
Hotary KB, Yana I, Sabeh F, Li XY, Holmbeck K, Birkedal-Hansen H, Allen ED, Hiraoka N, Weiss SJ . 2002 J. Exp. Med. 195: 295–308
Hudson MA, McReynolds LM . 1997 J. Natl. Cancer Inst. 89: 709–717
Kobayashi H, Gotoh J, Fujie M, Shinohara H, Moniwa N, Terao T . 1994a Int. J. Cancer 57: 727–733
Kobayashi H, Gotoh J, Shinohara H, Moniwa N, Terao T . 1994b Thromb. Haemost. 71: 474–480
Kono K, Salazar-Onfray E, Petersson M, Hansson J, Masucci G, Wasserman K, Nakazawa T, Anderson P, Kiessling R . 1996 Eur. J. Immunol. 26: 1308–1313
Kook YH, Adamski J, Zelent A, Ossowski L . 1994 EMBO J. 13: 3983–3991
Kulkarni AB, Huh CG, Becker D, Geiser A, Lyght M, Flanders KC, Roberts AB, Sporn MB, Ward JM, Karlsson S . 1993 Proc. Natl. Acad. Sci. USA 90: 770–774
Lanza F, Castoldi GL, Castagnari B, Todd III RF, Moretti S, Spisani S, Latorraca A, Focarile E, Roberti MG, Traniello S . 1998 Br. J. Haematol. 103: 110–123
Lee SL, Dickson RB, Lin CY . 2000 J. Biol. Chem. 275: 36720–36725
Leek RD, Hunt NC, Landers RJ, Lewis CE, Royds JA, Harris AL . 2000 J. Pathol. 190: 430–436
Leek RD, Lewis CE, Whitehouse R, Greenall M, Clarke J, Harris AL . 1996 Cancer Res. 56: 4625–4629
Leethanakul C, Patel V, Gillespie J, Pallente M, Ensley JF, Koontongkaew S, Liotta LA, Emmert-Buck M, Gutkind JS . 2000 Oncogene 19: 3220–3224
Liotta LA, Tryggvason K, Garbisa S, Hart I, Foltz CM, Shafie S . 1980 Nature 284: 67–68
List K, Jensen ON, Bugge TH, Lund LR, Ploug M, Danø K, Behrendt N . 2000 Biochemistry 39: 508–515
Loskutoff DJ, Curriden SA, Hu G, Deng G . 1999 Apmis 107: 54–61
Lund LR, Romer J, Bugge TH, Nielsen BS, Frandsen TL, Degen JL, Stephens RW, Danø K . 1999 EMBO J. 18: 4645–4656
Mantovani A, Bottazzi B, Colotta F, Sozzani S, Ruco L . 1992 Immunol. Today 13: 265–270
Martin DC, Fowlkes JL, Babic B, Khokha R . 1999 J. Cell Biol. 146: 881–892
May AE, Kanse SM, Lund LR, Gisler RH, Imhof BA, Preissner KT . 1998 J. Exp. Med. 188: 1029–1037
McMahon GA, Petitclerc E, Stefansson S, Smith E, Wong MK, Westrick RJ, Ginsburg D, Brooks PC, Lawrence DA . 2001 J. Biol. Chem. 276: 33964–33968
Min HY, Doyle LV, Vitt CR, Zandonella CL, Stratton-Thomas JR, Shuman MA, Rosenberg S . 1996 Cancer Res. 56: 2428–2433
Montgomery AM, Reisfeld RA, Cheresh DA . 1994 Proc. Natl. Acad. Sci. USA 91: 8856–8860
Morita S, Sato A, Hayakawa H, Ihara H, Urano T, Takada Y, Takada A . 1998 Int. J. Cancer 78: 286–292
Mueller BM, Yu YB, Laug WE . 1995 Proc. Natl. Acad. Sci. USA 92: 205–209
Nekarda H, Siewert JR, Schmitt M, Ulm K . 1994 Lancet 343: 117
Nicole O, Docagne F, Ali C, Margaill I, Carmeliet P, MacKenzie ET, Vivien D, Buisson A . 2001 Nat. Med. 7: 59–64
Nielsen BS, Sehested M, Timshel S, Pyke C, Danø K . 1996 Lab. Invest. 74: 168–177
O'Reilly MS, Boehm T, Shing Y, Fukai N, Vasios G, Lane WS, Flynn E, Birkhead JR, Olsen BR, Folkman J . 1997 Cell 88: 277–285
O'Reilly MS, Holmgren L, Shing Y, Chen C, Rosenthal RA, Moses M, Lane WS, Cao Y, Sage EH, Folkman J . 1994 Cell 79: 315–328
Odekon LE, Blasi F, Rifkin DB . 1994 J. Cell. Physiol. 158: 398–407
Ohmori T, Okada K, Arita N, Watanabe Y, Miyazaki T, Tabei R . 1995 Histol. Histopathol. 10: 789–794
Oka T, Ishida T, Nishino T, Sugimachi K . 1991 Cancer Res. 51: 3522–3525
Ossowski L . 1988 Cell 52: 321–328
Ossowski L, Aguirre-Ghiso JA . 2000 Curr. Opin. Cell. Biol. 12: 613–620
Ossowski L, Reich E . 1983 Cell 35: 611–619
Pedersen H, Brunner N, Francis D, Osterlind K, Ronne E, Hansen HH, Danø K, Grondahl-Hansen J . 1994 Cancer Res. 54: 4671–4675
Pilcher BK, Dumin JA, Sudbeck BD, Krane SM, Welgus HG, Parks WC . 1997 J. Cell Biol. 137: 1445–1457
Platt N, da Silva RP, Gordon S . 1998 Trends Cell. Biol. 8: 365–372
Plesner T, Ralfkiaer E, Wittrup M, Johnsen H, Pyke C, Pedersen TL, Hansen NE, Danø K . 1994 Am. J. Clin. Pathol. 102: 835–841
Plow EF, Edgington TS . 1986 J. Immunol. 137: 1910–1915
Plow EF, Freaney DE, Plescia J, Miles LA . 1986 J. Cell Biol. 103: 2411–2420
Prendergast GC, Diamond LE, Dahl D, Cole MD . 1990 Mol. Cell. Biol. 10: 1265–1269
Pyke C, Graem N, Ralfkiaer E, Ronne E, Hoyer-Hansen G, Brunner N, Danø K . 1993 Cancer Res. 53: 1911–1915
Pyke C, Kristensen P, Ralfkiaer E, Eriksen J, Danø K . 1991a Cancer Res. 51: 4067–4071
Pyke C, Kristensen P, Ralfkiaer E, Grondahl-Hansen J, Eriksen J, Blasi F, Danø K . 1991b Am. J. Pathol. 138: 1059–1067
Pyke C, Ralfkiaer E, Ronne E, Hoyer-Hansen G, Kirkeby L, Danø K . 1994 Histopathology 24: 131–138
Rabbani SA, Harakidas P, Davidson DJ, Henkin J, Mazar AP . 1995 Int. J. Cancer 63: 840–845
Rifkin DB, Mazzieri R, Munger JS, Noguera I, Sung J . 1999 Apmis 107: 80–85
Rogove AD, Siao C, Keyt B, Strickland S, Tsirka SE . 1999 J. Cell. Sci. 112: 4007–4016
Romisch J, Vermohlen S, Feussner A, Stohr H . 1999 Haemostasis 29: 292–299
Sabapathy KT, Pepper MS, Kiefer F, Mohle-Steinlein U, Tacchini-Cottier F, Fetka I, Breier G, Risau W, Carmeliet P, Montesano R, Wagner EF . 1997 J. Cell Biol. 137: 953–963
Sato Y, Tsuboi R, Lyons R, Moses H, Rifkin DB . 1990 J. Cell Biol. 111: 757–763
Sawaya R, Highsmith R . 1988 J. Neurosurg. 68: 73–79
Schmidt M, Schler G, Gruensfelder P, Muller J, Hoppe F . 2000 Head Neck 22: 498–504
Shapiro RL, Duquette JG, Roses DF, Nunes I, Harris MN, Kamino H, Wilson EL, Rifkin DB . 1996 Cancer Res. 56: 3597–3604
Shull MM, Ormsby I, Kier AB, Pawlowski S, Diebold RJ, Yin M, Allen R, Sidman C, Proetzel G, Calvin D et al . 1992 Nature 359: 693–699
Sier CF, Stephens R, Bizik J, Mariani A, Bassan M, Pedersen N, Frigerio L, Ferrari A, Danø K, Brunner N, Blasi F . 1998 Cancer Res. 58: 1843–1849
Simon DI, Ezratty AM, Francis SA, Rennke H, Loscalzo J . 1993 Blood 82: 2414–2422
Skriver L, Larsson LI, Kielberg V, Nielsen LS, Andresen PB, Kristensen P, Danø K . 1984 J. Cell Biol. 99: 752–757
Solberg H, Ploug M, Hoyer-Hansen G, Nielsen BS, Lund LR . 2001 J. Histochem. Cytochem. 49: 237–246
Stefansson S, Lawrence DA . 1996 Nature 383: 441–443
Stefansson S, Petitclerc E, Wong MK, McMahon GA, Brooks PC, Lawrence DA . 2001 J. Biol. Chem. 276: 8135–8141
Sunderkotter C, Steinbrink K, Goebeler M, Bhardwaj R, Sorg C . 1994 J. Leukoc. Biol. 55: 410–422
Takeuchi T, Harris JL, Huang W, Yan KW, Coughlin SR, Craik CS . 2000 J. Biol. Chem. 275: 26333–26342
Taniguchi T, Kakkar AK, Tuddenham EG, Williamson RC, Lemoine NR . 1998 Cancer Res. 58: 4461–4467
Wahl LM, Kleinman HK . 1998 J. Natl. Cancer Inst. 90: 1583–1584
Werb Z . 1997 Cell 91: 439–442
Whitelock JM, Murdoch AD, Iozzo RV, Underwood PA . 1996 J. Biol. Chem. 271: 10079–10086
Yu HR, Schultz RM . 1990 Cancer Res. 50: 7623–7633
Acknowledgements
We thank Drs Henning Birkedal-Hansen, Silvio Gutkind and Mary Jo Danton for critically reading the manuscript. We also thank Adriana Zabaleta for her excellent technical assistance. This work was supported by grants from the National Institutes of Health to Daniel A Lawrence (R01 HL55747, P01 HL54710).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Curino, A., Mitola, D., Aaronson, H. et al. Plasminogen promotes sarcoma growth and suppresses the accumulation of tumor-infiltrating macrophages. Oncogene 21, 8830–8842 (2002). https://doi.org/10.1038/sj.onc.1205951
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.onc.1205951
Keywords
This article is cited by
-
Exosomes in the tumor microenvironment of sarcoma: from biological functions to clinical applications
Journal of Nanobiotechnology (2022)
-
Spontaneous lung and lymph node metastasis in transgenic breast cancer is independent of the urokinase receptor uPAR
Clinical & Experimental Metastasis (2015)
-
Species-specific urokinase receptor ligands reduce glioma growth and increase survival primarily by an antiangiogenesis mechanism
Laboratory Investigation (2004)
-
Host-derived plasminogen activator inhibitor-1 (PAI-1) concentration is critical for in vivo tumoral angiogenesis and growth
Oncogene (2004)